Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v9-FR
Language English French
Date Updated 2019-09-25 2019-06-25
Drug Identification Number 02318679 02318679
Brand name OLMETEC OLMETEC
Common or Proper name Olmesartan Medoxomil tablets Olmesartan Medoxomil tablets
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients OLMESARTAN MEDOXOMIL OLMESARTAN MEDOXOMIL
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-06-04 2019-06-04
Actual start date 2019-05-14 2019-05-14
Estimated end date 2019-09-27 2019-08-16
Actual end date 2019-09-24
Shortage status Resolved Actual shortage
Company comments Partial orders were released on July 16. Partial re-supply is expected in Mid-July.
Health Canada comments